全文获取类型
收费全文 | 10126篇 |
免费 | 1443篇 |
国内免费 | 277篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 140篇 |
妇产科学 | 68篇 |
基础医学 | 2182篇 |
口腔科学 | 312篇 |
临床医学 | 926篇 |
内科学 | 1318篇 |
皮肤病学 | 226篇 |
神经病学 | 351篇 |
特种医学 | 405篇 |
外国民族医学 | 1篇 |
外科学 | 1291篇 |
综合类 | 1391篇 |
现状与发展 | 1篇 |
一般理论 | 7篇 |
预防医学 | 1190篇 |
眼科学 | 99篇 |
药学 | 924篇 |
6篇 | |
中国医学 | 492篇 |
肿瘤学 | 451篇 |
出版年
2024年 | 32篇 |
2023年 | 282篇 |
2022年 | 395篇 |
2021年 | 656篇 |
2020年 | 542篇 |
2019年 | 590篇 |
2018年 | 505篇 |
2017年 | 529篇 |
2016年 | 553篇 |
2015年 | 612篇 |
2014年 | 723篇 |
2013年 | 909篇 |
2012年 | 668篇 |
2011年 | 794篇 |
2010年 | 606篇 |
2009年 | 520篇 |
2008年 | 590篇 |
2007年 | 452篇 |
2006年 | 403篇 |
2005年 | 244篇 |
2004年 | 238篇 |
2003年 | 213篇 |
2002年 | 129篇 |
2001年 | 90篇 |
2000年 | 77篇 |
1999年 | 57篇 |
1998年 | 71篇 |
1997年 | 50篇 |
1996年 | 36篇 |
1995年 | 25篇 |
1994年 | 33篇 |
1993年 | 22篇 |
1992年 | 18篇 |
1991年 | 21篇 |
1990年 | 13篇 |
1989年 | 18篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 9篇 |
1985年 | 17篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1975年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
2.
《Journal of pharmaceutical sciences》2019,108(11):3515-3520
Particle size analysis in the pharmaceutical industry has long been a source of debate regarding how best to define measurement accuracy; the degree to which the result of a measurement or calculation conforms to the true value. Defining a “true” value for the size of a particle can be challenging as the output of its measurement will differ because of variations in measurement approaches, instrumental differences and calculation methods. Consequently, for “real” particles, a universal “true” value does not exist and accuracy is therefore not a definable characteristic. Accordingly, precision is then a measure of the ability to reproducibly achieve a measurement of unknown relevance.This article proposes, in place of accuracy, a means to define the “appropriateness” of a measurement in line with the critical quality attributes (CQA) of the material being characterized. The decision as to whether the measurement is correct should involve a link to the CQA; that is, correlation should be demonstrated, without which the measured particle size cannot be defined as a critical material attribute.Correspondingly, methods should also be able to provide sufficient precision to demonstrate discrimination relating to variation in the CQA. The benefits and challenges of this approach are discussed. 相似文献
3.
4.
The midwifery art has emphasised the uniqueness of human beings throughout its Nordic history. The educated Nordic midwife has in the last decade celebrated several hundred years of memories. This article studies how the key ideas of the midwifery art and patterns of ideas become evident in the zeitgeist from the beginning of the 19th century to the millennium in the Nordic countries. The legacy and pattern of ideas of the art of midwifery are interpreted in relation to the texts of the selected historical sources and based on Ricoeur's phenomenological-hermeneutic approach to the text and further to the dedication of understanding and interpretation. The historical sources refer to unprinted primary sources from historical archives and printed secondary and tertiary sources. The patterns of ideas include a tripartite whole: the true cultivation of the head, the philosophy and aesthetics of the hand, the strength of the heart and the drive of calling. These ideas open for unique visions and attest to the evident in modern midwives. Today's midwives have academic training with examinations, and the education is based on scientific evidence. The midwife profession is authorised by the state and supervised by the authorities. 相似文献
5.
6.
7.
8.
《Journal of pharmaceutical sciences》2019,108(11):3521-3523
We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time. 相似文献
9.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献10.